Navigation Links
AVACEN Medical Patent Issued
Date:7/1/2015

SAN DIEGO, July 1, 2015 /PRNewswire/ -- AVACEN, Inc. announced today the issue by the US Patent Office of a second AVACEN patent covering the medical technology platform supporting its unique Dry Heat Therapy AVACEN 100 product.

Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO

The apparatus and methods patent no. 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal Energy shields certain medical devices manufactured by AVACEN and specific methods of use, referred to by the company as the AVACEN Treatment Method.

The patent consists of 20 claims related to innovations introduced in AVACEN's medical technology that allow multiple therapeutic uses to alleviate a symptom associated with a circulatory, neurological, lymphatic, or endocrinal dysfunction, or any combination thereof.

"This further protects AVACEN's multi-million dollar investment in developing the AVACEN Treatment Method and our first commercial product, the AVACEN 100, which is designed for sufferers of pain related to arthritis and fibromyalgia*," said Thomas G. Muehlbauer, Chairman and CEO, AVACEN Medical.

In January of 2015 AVACEN Medical filed a De Novo application with the FDA to approve its marketing of the AVACEN 100 to sufferers of fibromyalgia.

Fibromyalgia is a complex chronic pain disorder that affects an estimated 10 million Americans. For those with severe symptoms, fibromyalgia can be extremely debilitating and interfere with basic daily activities. "Patent approvals of the AVACEN Treatment Method along with our encouraging Fibromyalgia Clinical Study and anecdotal results are giant steps forward when it comes to commercializing our intellectual property to relieve the pain associated with this terrible disease," added Mr. Muehlbauer.

About the AVACEN 100: In March of 2014 the US Patent Office issued Patent No. 8,679,170 to AVACEN covering key aspects of their medical technology platform and in August of 2014 the FDA cleared the AVACEN 100 as a Class II medical device for the temporary relief of joint pain associated with arthritis; muscle spasms; minor strains and sprains; and muscular relaxation.

About AVACEN: AVACEN Medical is dedicated to the innovation and design of safe, easy to use, noninvasive drug free alternatives to treat pain associated with diseases such as arthritis, fibromyalgia and migraines.

Contact: Ryan Jeffcoat at (888) 4-AVACEN x 711 or Email.

* The AVACEN 100 is pending approval for widespread pain related to fibromyalgia at the U.S. FDA and is not available for sale in the U.S. or globally for that indication.


'/>"/>
SOURCE AVACEN, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode
2. Vasomedical Announces Financial Results for the First Quarter of 2013
3. CCS Medical Moves Forward as Medicare Winner
4. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
5. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
6. RAD Technology Medical Systems Delivers Innovative Time Saving Modular Construction At New Swedish Cancer Institute Facility
7. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
8. ACLS Online Course Manuals are Now Available at No Cost through United Medical Education
9. Statistical Challenges in Medical Device Trail Evaluation
10. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
11. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Calif. , Oct. 11, 2017  BioPharmX Corporation ... scientific team that developed an innovative way to use ... of the delivery of new drugs. ... Fall Clinical Dermatology Conference will show how researchers from ... Hospital, Harvard Medical School used a suite of imaging ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
Breaking Medicine Technology:
(Date:10/13/2017)... Worth, TX (PRWEB) , ... October 13, 2017 ... ... financial planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, ... young boy fighting to overcome a rare and deadly chromosome abnormality. , After ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of ... part of a disaster drill on October 3rd. , Apple Rehab participated with the ... as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):